​

Cellyan Biotechnology Ownership | Who Owns Cellyan Biotechnology?


OverviewChart

Cellyan Biotechnology Ownership Summary


Cellyan Biotechnology is owned by 1.04% institutional investors, 17.34% insiders, and 81.62% retail investors. Stonex group is the largest institutional shareholder, holding 0.56% of HKPD shares.

HKPD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCellyan Biotechnology1.04%17.34%81.62%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryMedical Distribution Stocks27.95%20.92%51.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Stonex group132.31K0.56%$33.88K
Hrt financial lp100.67K0.43%$11.00K
Jane street group81.79K0.35%$9.49K
Jpmorgan chase112.000.00%$12.00
Two sigma investments, lp---
Ubs group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonex group132.31K0.00%$33.88K
Jane street group81.79K-$9.49K
Two sigma investments, lp---
Jpmorgan chase112.00-$12.00
Ubs group---
Hrt financial lp100.67K-$11.00K

Top Buyers

HolderShares% AssetsChange
Hrt financial lp100.67K-58.85K
Jane street group81.79K-32.70K
Stonex group132.31K0.00%30.00K
Jpmorgan chase112.00-112.00
Ubs group---1.08K

Top Sellers

HolderShares% AssetsChange
Two sigma investments, lp---10.83K
Ubs group---1.08K
Jpmorgan chase112.00-112.00
Stonex group132.31K0.00%30.00K
Jane street group81.79K-32.70K

New Positions

HolderShares% AssetsChangeValue
Jpmorgan chase112.00-112.00$12.00

Sold Out

HolderChange
Ubs group-1.08K
Two sigma investments, lp-10.83K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026650.00%245,251293.31%11482.51%5---100.00%
Mar 31, 20264-62,356-15.27%-119.17%--100.00%3-
Dec 31, 20254100.00%73,590507.33%-5186.42%3200.00%--100.00%
Sep 30, 20252-66.67%12,117-83.53%-23.17%1-75.00%1-50.00%
Jun 30, 2025650.00%73,56142.34%-285.08%4-2-

HKPD Ownership FAQ


Who Owns Cellyan Biotechnology?

Cellyan Biotechnology shareholders are primarily institutional investors at 1.04%, followed by 17.34% insiders and 81.62% retail investors. The average institutional ownership in Cellyan Biotechnology's industry, Medical Distribution Stocks, is 27.95%, which Cellyan Biotechnology falls below.

Who owns the most shares of Cellyan Biotechnology?

Cellyan Biotechnology’s largest shareholders are Stonex group (132.31K shares, 0.56%), Hrt financial lp (100.68K shares, 0.43%), and Jane street group (81.79K shares, 0.35%). Together, they hold 1.34% of Cellyan Biotechnology’s total shares outstanding.

Does Blackrock own Cellyan Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Cellyan Biotechnology.

Who is Cellyan Biotechnology’s biggest shareholder by percentage of total assets invested?

Stonex group is Cellyan Biotechnology’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 132.31K Cellyan Biotechnology shares, valued at 33.88K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools